NCT06309589View on ClinicalTrials.gov

The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

December 31, 2023

Conditions
Primary Biliary Cholangitis
Interventions
DRUG

Vitamin D

experimental group received UDCA combined with vitamin D3 (1200 IU per day) treatment

Trial Locations (1)

830001

People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi

All Listed Sponsors
lead

Yilihamu·Abilitifu

OTHER